CN118946346A - 剂型内包衣和其应用 - Google Patents

剂型内包衣和其应用 Download PDF

Info

Publication number
CN118946346A
CN118946346A CN202380024059.1A CN202380024059A CN118946346A CN 118946346 A CN118946346 A CN 118946346A CN 202380024059 A CN202380024059 A CN 202380024059A CN 118946346 A CN118946346 A CN 118946346A
Authority
CN
China
Prior art keywords
mass
dosage form
coating formulation
choline
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380024059.1A
Other languages
English (en)
Chinese (zh)
Inventor
克莱顿·埃里克森
任·A·冈萨雷斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bairkang Co
Original Assignee
Bairkang Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bairkang Co filed Critical Bairkang Co
Publication of CN118946346A publication Critical patent/CN118946346A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN202380024059.1A 2022-03-11 2023-03-10 剂型内包衣和其应用 Pending CN118946346A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263318946P 2022-03-11 2022-03-11
US63/318,946 2022-03-11
PCT/US2023/064173 WO2023173111A2 (en) 2022-03-11 2023-03-10 Intra-dosage form coatings and applications thereof

Publications (1)

Publication Number Publication Date
CN118946346A true CN118946346A (zh) 2024-11-12

Family

ID=87936115

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380024059.1A Pending CN118946346A (zh) 2022-03-11 2023-03-10 剂型内包衣和其应用

Country Status (6)

Country Link
US (1) US20250073175A1 (https=)
EP (1) EP4489731A4 (https=)
JP (1) JP2025506698A (https=)
KR (1) KR20250023329A (https=)
CN (1) CN118946346A (https=)
WO (1) WO2023173111A2 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007419D0 (en) * 2000-03-27 2000-05-17 Smithkline Beecham Gmbh Composition
US20070292508A1 (en) * 2006-06-05 2007-12-20 Balchem Corporation Orally disintegrating dosage forms
CA3013795A1 (en) * 2016-02-17 2017-08-24 Corr-Jensen Inc. Time release vitamins and minerals in edible oils
US20220193033A1 (en) * 2019-04-30 2022-06-23 Dsm Ip Assets B.V. New delivery system for specific water-soluble vitamins

Also Published As

Publication number Publication date
EP4489731A4 (en) 2026-03-11
EP4489731A2 (en) 2025-01-15
KR20250023329A (ko) 2025-02-18
WO2023173111A3 (en) 2023-12-07
US20250073175A1 (en) 2025-03-06
WO2023173111A2 (en) 2023-09-14
JP2025506698A (ja) 2025-03-13

Similar Documents

Publication Publication Date Title
TWI410258B (zh) 維生素及礦物質補充劑中穩定性之改良
WO2020044116A1 (en) Therapeutic combinations of cannabinoids with curcumin
US20150030676A1 (en) Stablized modified release folic acid derivative composition, its therapeutic use and methods of manufacture
US20210205236A1 (en) Therapeutic combinations of boswellia extract and cannabinoids
KR102416361B1 (ko) 루테인 및/또는 제아잔틴의 신규 타정가능 제형
US20210338629A1 (en) Oral formulations of phenylalanine and cannabinoids
JP2018104393A (ja) 固形製剤
CN118946346A (zh) 剂型内包衣和其应用
JP2000281574A (ja) 心臓血管保健のためのビタミン処方物
JP4674955B2 (ja) アミノ糖含有製剤
US9549937B2 (en) Composition containing phospholipid-DHA and folate
US9610302B2 (en) Composition containing phospholipid-DHA and B vitamins
EP2893928B1 (en) Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition
AU2016386385B2 (en) Stable and palatable composition of vitamin C and zinc lozenge tablets
JP2001122788A (ja) 医薬用固形組成物
JP2018145181A (ja) ビタミンｂ１類配合錠剤
US20250275926A1 (en) Multilayer formulation comprising modified tapioca starch for controlled-release of active agents
KR20230065181A (ko) 티아민 또는 그의 유도체와 피돌산 마그네슘을 포함하는 경구용 조성물 및 복합 제제
KR101893110B1 (ko) 비페닐디메틸디카르복실레이트 및 마늘유를 포함하는 제제
JP3895757B1 (ja) 粉末状組成物
JP2022165922A (ja) 固形組成物
EP4233848A1 (en) Soft gel capsule preparations
JP2011068614A (ja) ビタミン製剤
JP2019199486A (ja) アミノ糖含有製剤
JP2017214432A (ja) アミノ糖含有製剤

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination